8.73 stock price down
Change
- 0.16 (1.80%)
Volume
4,500
Exchange
NASDAQ
3:59 PM ET on Nov 26, 2014
Delayed at least 20 minutes.
Provided by eSignal.
3.32 stock price down
Change
- 0.04 (1.07%)
Volume
118,346
Exchange
TASE
3:24 PM IT on Nov 26, 2014
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Nov 10, 2014
FDA Grants QIDP Fast-Track Designation to RedHill Biopharma's Phase III H. pylori Drug RHB-105

Nov 10, 2014
RedHill Biopharma Reports Results for the Third Quarter of 2014

Oct 28, 2014
RedHill Biopharma to Host Third Quarter 2014 Financial Results Conference Call on November 10, 2014

View all »Upcoming Events & Presentations

Dec 10, 2014 - Dec 10, 2014 at 8:30 AM
RedHill Presentation - Gelbart Kahana Biomed Conference
Tel-Aviv Stock Exchange, Ahuzat Bayit St. 4, Isreal

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com